Completed
A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)
NCT04626297
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
- Locations
-
- Clinical Research Center of Alabama- Birmingham Birmingham, Alabama, United States
- Burke Pharmaceutical Research Hot Springs, Arkansas, United States
- Arkansas Research Trials North Little Rock, Arkansas, United States
- Orange County Research Institute Anaheim, California, United States